The Use of F-18-FDG PET/CT in Renal and Bladder Tumors

Journal Title: Nuclear Medicine Seminars - Year 2019, Vol 5, Issue 3

Abstract

Clinical imaging has been the cornerstone to guide patient management and therapy strategies for oncology patients. In the last decades, the use of fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) has been increased and PET/CT has been introduced as the major imaging technique in international guidelines for staging and re-staging of many cancer types as well as for assessment of therapy response in oncological imaging. In this review, the contribution of fluorodeoxyglucose PET/CT in renal and bladder tumors is discussed under current guidelines.

Authors and Affiliations

Burcu Esen Akkaş

Keywords

Related Articles

Procedure Guideline for Lymphoscintigraphy and Sentinel Lymph Node: Malignant Melanoma

Malignant melanoma is still among the most fatal cancers worldwide with increasing incidence. Lymphoscintigraphy and gamma probe guided sentinel lymph node detection is an established procedure which has a great impact i...

Quality Control of Magistral (or in House or Smallscale) Produced Radiopharmaceuticals

As it is known, magistral radiopharmaceuticals are suitable for only in house use and are prepared, produced and supplied with a medical prescription for a certain patient in good laboratory practice (GLP) standard by a...

F-18 FDG PET/CT Practice Guideline in Oncology

Positron emission tomography (PET) is a tomographic imaging method that shows three-dimensional distribution of radiopharmaceuticals which are labelled with positron emitter radionuclides. Today most widely used PET radi...

Guideline for the Treatment of Liver Cancer with Y-90 Radiomicrosphere

Yttrium-90 microsphere therapy, which has become more common in recent years, offers an effective and safe radionuclide treatment option in the treatment of primary and metastatic liver tumors. The success of the treatme...

New Radionuclides in Pain Palliation

Skeletal system is the most common metastasis site in patients with advanced cancer. Pain is an important health problem in patients with bone metastasis. Bone seeking radionuclides to treat bone pain due to bone metasta...

Download PDF file
  • EP ID EP685340
  • DOI 10.4274/nts.galenos.2019.0028
  • Views 168
  • Downloads 0

How To Cite

Burcu Esen Akkaş (2019). The Use of F-18-FDG PET/CT in Renal and Bladder Tumors. Nuclear Medicine Seminars, 5(3), -. https://europub.co.uk/articles/-A-685340